1. Home
  2. WRAP vs MXCT Comparison

WRAP vs MXCT Comparison

Compare WRAP & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wrap Technologies Inc.

WRAP

Wrap Technologies Inc.

HOLD

Current Price

$1.45

Market Cap

82.8M

Sector

Industrials

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.07

Market Cap

93.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRAP
MXCT
Founded
2016
1999
Country
United States
United States
Employees
25
N/A
Industry
Ordnance And Accessories
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.8M
93.0M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
WRAP
MXCT
Price
$1.45
$1.07
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
186.3K
941.5K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,672,000.00
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.50
P/E Ratio
N/A
N/A
Revenue Growth
3.66
N/A
52 Week Low
$1.20
$0.64
52 Week High
$3.23
$2.40

Technical Indicators

Market Signals
Indicator
WRAP
MXCT
Relative Strength Index (RSI) 45.44 66.10
Support Level $1.41 $0.77
Resistance Level $1.60 $1.16
Average True Range (ATR) 0.09 0.08
MACD -0.00 0.02
Stochastic Oscillator 14.56 74.73

Price Performance

Historical Comparison
WRAP
MXCT

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: